Article
08 Jun 2026
Hikma V. Amarin: It’s Not Just About Skinny Labels
AUTHORS CONTENT
Article
26 Jun 2025
The Enlarged Board Of Appeal Of The EPO Further Aligns Claim Construction With U.S. And U.K.
Article
27 May 2025
Reshaped IPR Landscape: Narrower Estoppel And Fewer New Cases
Article
17 Feb 2025
Patentable Subject Matter And Elephants: Knowing It When You See It
Article
09 Oct 2024
Supreme Court Declines Certiorari Review In Cellect
Article
30 Aug 2024
Patent Term Adjustment And ODP: USPTO Defends Federal Circuit's Cellect Decision
Article
31 May 2024
Foley Hoag Tells Supreme Court That Congressional Guarantees For Patents Are Being Negated By Courts
Article
20 May 2024
In Re Cellect: What's The Issue And What To Expect
Article
17 May 2024
FTC Challenges More Patent Listings In The FDA's Orange Book
Article
09 Oct 2023
Is The United States' Nonobviousness Test 'Plausibly' Similar To The EPO/UK Inventive Step Standard?
Article
13 Sep 2023
Is There A Step Between ‘Inventive' And ‘Nonobviousness'?
Article
29 Jun 2023
New York May Soon Ban Use Of Non-Compete Agreements
Article
25 May 2023
The Fate Of The Skinny Label: Teva Pharmaceuticals USA, Inc. V. GlaxoSmithKline LLC
Article
23 May 2023
Previewing Generic's Skinny Label: Supreme Court To Rule On Teva's Certiorari Petition
Article
26 Jan 2023
Never Mind: Supreme Court Dismisses Attorney-Client Privilege Case After Oral Argument
Article
02 Nov 2022
A Hatch-Waxman Review: What To Know About The Hatch-Waxman Act As It Turns 39+
Article
13 Jul 2022
Growing Consensus That Trade Secret Claims Must Be Pleaded With Particularity In New York And Elsewhere
Article
02 Jul 2021
Supreme Court In Minerva Surgical Inc. V. Hologic Inc., Upholds But Limits The Scope Of The Equitable Doctrine Of Assignor Estoppel